Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-CARE: Denosumab in Early-Stage Breast Cancer
NCT01077154Phase 3Terminated
- Sponsor
- Amgen
- Start
- Jun 2010
- Primary completion
- Aug 2017
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 39
01
Overview
A Phase 3 trial of denosumab in breast cancer, sponsored by Amgen. Started Jun 2010; status: terminated.
02
Drugs
denosumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01077154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01077154.